FDA would limit input of doctors paid by drug firms
$50,000 is set as cutoff
Amid disclosures that the pharmaceutical industry has funneled millions of dollars to leading physicians, the Food and Drug Administration yesterday moved to bar scientists from serving as advisers to the agency if they have financial ties to drug and medical-device companies exceeding $50,000. (Full article: 955 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
Waiting for Twitter to feed in the latest...